South America Multiplex Assays Market

South America Multiplex Assays Market Research Report By Application (Clinical Diagnostics, Drug Discovery, Environmental Testing, Food Safety Testing, Genetic Research), By Technology (Luminex xMAP Technology, Magnetic Bead-Based Assays, Flow Cytometry, PCR, ELISA), By Platform (Microarray Platforms, Nucleic Acid Platforms, Protein Platforms, Cell-Based Platforms), By End User (Hospitals, Laboratories, Research Institutions, Pharmaceutical Companies) andBy Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

Forecast Period
2025 - 2035
CAGR
7.69%
2024 Market Size
$ 309.83 Million
2035 Market Size
$ 700 Million
Healthcare ● Updated February 2026 Report ID: MRFR/HC/51934-HCR | Pages: 200 | Author: Nidhi Mandole, Garvit Vyas
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Application (USD Million)
      1. 4.1.1 Clinical Diagnostics
      2. 4.1.2 Drug Discovery
      3. 4.1.3 Environmental Testing
      4. 4.1.4 Food Safety Testing
      5. 4.1.5 Genetic Research
    2. 4.2 Construction, BY Technology (USD Million)
      1. 4.2.1 Luminex xMAP Technology
      2. 4.2.2 Magnetic Bead-Based Assays
      3. 4.2.3 Flow Cytometry
      4. 4.2.4 PCR (Polymerase Chain Reaction)
      5. 4.2.5 ELISA (Enzyme-Linked Immunosorbent Assay)
    3. 4.3 Construction, BY Platform (USD Million)
      1. 4.3.1 Microarray Platforms
      2. 4.3.2 Nucleic Acid Platforms
      3. 4.3.3 Protein Platforms
      4. 4.3.4 Cell-Based Platforms
    4. 4.4 Construction, BY End User (USD Million)
      1. 4.4.1 Hospitals
      2. 4.4.2 Laboratories
      3. 4.4.3 Research Institutions
      4. 4.4.4 Pharmaceutical Companies
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Thermo Fisher Scientific (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Abbott Laboratories (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Roche Diagnostics (CH)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Agilent Technologies (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Bio-Rad Laboratories (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Merck KGaA (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 PerkinElmer (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Luminex Corporation (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Qiagen N.V. (NL)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
    4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY PLATFORM
    5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY END USER
    6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CONSTRUCTION
    9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
    12. 6.12 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
    14. 6.14 CONSTRUCTION, BY TECHNOLOGY, 2024 (% SHARE)
    15. 6.15 CONSTRUCTION, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
    16. 6.16 CONSTRUCTION, BY PLATFORM, 2024 (% SHARE)
    17. 6.17 CONSTRUCTION, BY PLATFORM, 2024 TO 2035 (USD Million)
    18. 6.18 CONSTRUCTION, BY END USER, 2024 (% SHARE)
    19. 6.19 CONSTRUCTION, BY END USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
      3. 7.2.3 BY PLATFORM, 2025-2035 (USD Million)
      4. 7.2.4 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

South America Construction Market Segmentation

Construction By Application (USD Million, 2025-2035)

  • Clinical Diagnostics
  • Drug Discovery
  • Environmental Testing
  • Food Safety Testing
  • Genetic Research

Construction By Technology (USD Million, 2025-2035)

  • Luminex xMAP Technology
  • Magnetic Bead-Based Assays
  • Flow Cytometry
  • PCR (Polymerase Chain Reaction)
  • ELISA (Enzyme-Linked Immunosorbent Assay)

Construction By Platform (USD Million, 2025-2035)

  • Microarray Platforms
  • Nucleic Acid Platforms
  • Protein Platforms
  • Cell-Based Platforms

Construction By End User (USD Million, 2025-2035)

  • Hospitals
  • Laboratories
  • Research Institutions
  • South America Multiplex Assays Market Companies
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.